“stem-cells” Archives

Entry Author Date Location
Brace Yourself: Biotech IPOs Are Beating Tech’s Big Names 08/13/12 National
SD at Center of Shire’s Plan for Regenerative Medicine Business 06/14/12 San Diego
Xconomist of the Week: Evan Snyder—Stem Cell Reality Check 05/25/12 San Diego
iPierian Zeroes In on Antibodies for Alzheimer’s, Neurodegeneration 05/21/12 San Francisco
Progress for Pervasis and InVivo: A Boost for Regenerative Efforts? 04/19/12 Boston
Adimab, ImmunoGen, OvaScience, & More Boston Life Sciences News 04/06/12 Boston
OvaScience Adds $37M for Fertility Treatments 04/04/12 Boston
Celladon Raises $43M, Wins Fast-Track Status for Heart Treatment 02/15/12 San Diego
Fate Therapeutics Names Biotech Vet Bill Rastetter as Chairman, Interim CEO 12/14/11 San Diego
Harvard Bioscience Tool Used in First Transplants of Synthetic Tracheae 12/01/11 Boston
AlloCure Stem Cell Trial Provides Glimpse of Promising Treatment for Kidney Damage 11/18/11 Boston
Geron Dumps Stem Cell R&D Programs, Axes 38% of Workforce 11/14/11 San Francisco
Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News 10/14/11 Boston
Amgen Mulls R&D Cuts, Thong Le Named WBBA Chairman, NanoString’s Version 2.0, & More Seattle-Area Life Sciences News 10/13/11 Seattle
Stem Cell Therapy: A Process With a Promise 10/10/11 Seattle
Geron Names Chip Scarlett, Former Proteolix, Tercica Boss, as New CEO 09/30/11 San Francisco
Excerpt from “The Body Politic: The Battle Over Science in America” 09/29/11 National
Ipierian Hires New CEO to Carry on With Stem Cells for Discovering Neurological Drugs 09/07/11 San Francisco
Thane Kreiner, the Biotech-Entrepreneur-Turned-Educator With 1 Billion People on His Mind 08/25/11 San Francisco
Time to Cure Cancer or Stash Cash Under the Mattress? 08/15/11 National
Advanced Cell Technology Starts Human Trials of Embryonic Stem Cells Under Strict FDA Supervision 07/20/11 Boston
SeaGen’s Big Day at the FDA, Hutch Nabs $20M HIV Grant, Allozyne’s Nasdaq Plan, & More Seattle-Area Life Sciences News 07/14/11 Seattle
Fate Therapeutics Trims Chemistry Staff, Bets on Biotech Drugs 07/07/11 National
iPierian Shakeup Continues, as Chairman Corey Goodman, Scientist Doug Melton Exit Stem Cell Startup 06/15/11 San Francisco
Termeer Joins Verastem Board 06/13/11 Boston
At The Great Lakes Stem Cell (Innovation) Center, Researchers Anxiously Wait For Technology To Take Off 06/08/11 Detroit Ann Arbor
Will Biotech Ever Again Captivate the Public Imagination, Like Facebook or LinkedIn? 05/16/11 National
iPierian, Stem Cell Startup With Big Science & Big Bucks, Axes Group of Top Executives 05/13/11 San Francisco
Takeda Bets on Fate Therapeutics 05/10/11 San Diego
Geron Nabs $25M Loan from Stem Cell Agency, Paves Way for State Support of Clinical Trials 05/05/11 San Francisco
Page 3 of 7 « previous page · next page »